Feduccia AA

Department of Research Development, MAPS Public Benefit Corp, Santa Cruz, California, USA.

8 papers · ORCID

Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study.

Colcott J, Guerin AA, Carter O +10

Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.

Feduccia AA, Jerome L, Mithoefer MC +1

Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.

Jerome L, Feduccia AA, Wang JB +5

Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.

Mithoefer MC, Feduccia AA, Jerome L +7

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.

Feduccia AA, Jerome L, Yazar-Klosinski B +3

Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine-Assisted Therapy for Posttraumatic Stress Disorder: A Review of the Evidence, Neurobiological Plausibility, and Clinical Significance.

Price CM, Feduccia AA, DeBonis K

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study.

Wolfson PE, Andries J, Feduccia AA +10

ArticlePsilocybin

Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.

Greenway KT, Garel N, Jerome L +1